1. Home
  2. SMID vs MDXH Comparison

SMID vs MDXH Comparison

Compare SMID & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Smith-Midland Corporation

SMID

Smith-Midland Corporation

N/A

Current Price

$34.25

Market Cap

211.2M

Sector

Industrials

ML Signal

N/A

Logo MDxHealth SA

MDXH

MDxHealth SA

N/A

Current Price

$3.31

Market Cap

183.4M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
SMID
MDXH
Founded
1960
2003
Country
United States
Belgium
Employees
N/A
N/A
Industry
Building Materials
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
211.2M
183.4M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
SMID
MDXH
Price
$34.25
$3.31
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$7.67
AVG Volume (30 Days)
4.0K
112.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
866.67
N/A
EPS
1.96
N/A
Revenue
$78,508,000.00
N/A
Revenue This Year
N/A
$30.31
Revenue Next Year
N/A
$18.38
P/E Ratio
$18.04
N/A
Revenue Growth
31.77
N/A
52 Week Low
$25.16
$1.36
52 Week High
$43.62
$5.33

Technical Indicators

Market Signals
Indicator
SMID
MDXH
Relative Strength Index (RSI) 43.62 41.26
Support Level $33.59 $3.05
Resistance Level $37.90 $3.78
Average True Range (ATR) 1.47 0.18
MACD 0.00 -0.03
Stochastic Oscillator 27.63 11.32

Price Performance

Historical Comparison
SMID
MDXH

About SMID Smith-Midland Corporation

Smith-Midland Corp through its subsidiaries invents, develops, manufactures, markets, sells, and installs precast concrete products for primary use in the construction, highway, utilities, and farming industries. The firm's customers are general contractors and federal, state, and local transportation authorities. Its products include Slenderwall, JJhooks, Softsound, Sierra Wall and Easi set. A substantial portion of the company's business is derived from local, state, and federal building projects. The company generates revenues predominantly from the sale, leasing, licensing, shipping, and installation of precast concrete products for the construction, utility, and farming industries.

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

Share on Social Networks: